Successful treatment of persistent chylopericardium with somatostatin after operation on ascending aorta.
case_report · Level V
Where this comes from
- Record sourced from PubMed, PMID 24694457.
- Also identified by DOI 10.1016/j.athoracsur.2013.11.078.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Chylopericardium after intrathoracic surgical procedures rarely occurs. Optimal guidelines for the management of chylopericardium are lacking. In this case report, we describe our experience in treating chylopericadium with somatostatin in a 47-year-old man who underwent replacement of the ascending aorta and aortic valvuloplasty after aortic rupture. Postoperatively, a late tamponade was drained, and microbiologic analyses confirmed chyle. Conservative treatment including total parental nutrition failed, so we initiated somatostatin treatment as a continuous perfusion, with good results.
Medical subject headings
- Aorta
- Aortic Aneurysm, Thoracic
- Pericardial Effusion
- Postoperative Complications
- Somatostatin